{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:27:45Z","timestamp":1791149265715,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.atherosclerosis.2006.12.010","type":"journal-article","created":{"date-parts":[[2007,1,17]],"date-time":"2007-01-17T00:38:30Z","timestamp":1168994310000},"page":"287-292","source":"Crossref","is-referenced-by-count":38,"title":["Rare APOA5 mutations\u2014Clinical consequences, metabolic and functional effects"],"prefix":"10.1016","volume":"194","author":[{"given":"Philippa J.","family":"Talmud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2006.12.010_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(01)00539-1","article-title":"The apoAI-CIII-AIV gene cluster","volume":"157","author":"Groenendijk","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2006.12.010_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.1064852","article-title":"An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing","volume":"294","author":"Pennacchio","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2006.12.010_bib3","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1194\/jlr.M500533-JLR200","article-title":"Evidence for a complex relationship between apoAV and apoCIII in patients with severe hypertriglyceridemia","volume":"47","author":"Schaap","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2006.12.010_bib4","doi-asserted-by":"crossref","first-page":"44512","DOI":"10.1074\/jbc.M106888200","article-title":"Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration","volume":"276","author":"van der Vliet","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2006.12.010_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1373\/clinchem.2004.040824","article-title":"The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins","volume":"51","author":"O\u2019Brien","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2006.12.010_bib6","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1161\/01.ATV.0000186189.26141.12","article-title":"Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants","volume":"25","author":"Grosskopf","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2006.12.010_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00041433-200406000-00002","article-title":"The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?","volume":"15","author":"van Dijk","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2006.12.010_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/01.mol.0000162320.54795.68","article-title":"The APOA1\/C3\/A4\/A5 gene cluster, lipid metabolism and cardiovascular disease risk","volume":"16","author":"Lai","year":"2005","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2006.12.010_bib9","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1093\/hmg\/11.24.3031","article-title":"Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels","volume":"11","author":"Pennacchio","year":"2002","journal-title":"Hum Mol Gen"},{"key":"10.1016\/j.atherosclerosis.2006.12.010_bib10","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.ygeno.2003.11.016","article-title":"Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11","volume":"83","author":"Olivier","year":"2004","journal-title":"Genomics"},{"key":"10.1016\/j.atherosclerosis.2006.12.010_bib11","doi-asserted-by":"crossref","first-page":"27941","DOI":"10.1074\/jbc.M403240200","article-title":"ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis","volume":"279","author":"Schaap","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2006.12.010_bib12","doi-asserted-by":"crossref","first-page":"21553","DOI":"10.1074\/jbc.M411412200","article-title":"Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase","volume":"280","author":"Merkel","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2006.12.010_bib13","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/01.ATV.0000203519.25116.54","article-title":"Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 Kinetics","volume":"26","author":"Chan","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2006.12.010_bib14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/01.ATV.0000153087.36428.dd","article-title":"Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia","volume":"25","author":"Oliva","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2006.12.010_bib15","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1172\/JCI24471","article-title":"Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment","volume":"115","author":"Marcais","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2006.12.010_bib16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.atherosclerosis.2006.04.010","article-title":"A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia","volume":"188","author":"Oliva","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2006.12.010_bib17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/01.mol.0000217892.00618.54","article-title":"APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency","volume":"17","author":"Calandra","year":"2006","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2006.12.010_bib18","doi-asserted-by":"crossref","first-page":"25383","DOI":"10.1074\/jbc.M501589200","article-title":"Apolipoprotein A-V-heparin interactions: implications for plasma lipoprotein metabolism","volume":"280","author":"Lookene","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2006.12.010_bib19","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1172\/JCI26712","article-title":"Give me A5 for lipoprotein hydrolysis!","volume":"115","author":"Merkel","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2006.12.010_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/S1567-5688(06)82022-2","article-title":"Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism","author":"Henneman","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2006.12.010_bib21","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s00125-006-0387-0","article-title":"APOA5 genotype, plasma apolipoprotein AV and triglyceride levels and the prospective risk of type 2 diabetes: results from the Northwick Park Heart Study II","volume":"49","author":"Talmud","year":"2006","journal-title":"Diabetalogia"},{"key":"10.1016\/j.atherosclerosis.2006.12.010_bib22","doi-asserted-by":"crossref","first-page":"28215","DOI":"10.1074\/jbc.M502144200","article-title":"Determination of the functionality of common APOA5 polmorphisms","volume":"280","author":"Talmud","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2006.12.010_bib23","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1093\/hmg\/11.24.3039","article-title":"Relative contribution of variation within the APOC3-A4-A5 gene cluster in determining plasma triglycerides","volume":"11","author":"Talmud","year":"2002","journal-title":"Hum Mol Gen"},{"key":"10.1016\/j.atherosclerosis.2006.12.010_bib24","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S1567-5688(06)82056-8","article-title":"Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family","volume":"7","author":"Nilsson","year":"2006","journal-title":"Athereosclerosis"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915006007544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915006007544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:24:27Z","timestamp":1547079867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915006007544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0021915006007544"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.12.010","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}